Amber List

COLLCollegium Pharmaceutical, Inc.

Healthcare · Drug Manufacturers - Specialty & Generic · small-cap ($1.0B)
-34.3%
from rolling 252-day high of $50.79 set 2025-12-29 · 150d ago
Current
$33.37
Decline depth
-34.3%
Decline σ
6.7σ
TFC
3/5 bearish
Rolling 252-day high Up day Down day Last 90 trading days · data from Alpaca

Since it joined the list

$COLL landed on the list 2026-03-03, down 21.3% from its 52-week high that day — now down -34.3%.

That's 10.5 percentage points deeper than the day it joined. It bottomed 40.0% below that high along the way.

Decline from the 52-week high as it stood on 2026-03-03 (fixed anchor) → today. Split-adjusted, Alpaca. Observed history, not a forecast.

Structural break signals

COLL qualifies for the Amber List on decline depth.

Decline depth
-34.3%
From rolling 252-day high of $50.79, 150d ago. Past the 30% Amber threshold.
Time-frame continuity
3/5 bearish
Latest bar across daily/weekly/monthly/quarterly/yearly time frames. A bar counts as bearish when it's a 2-Down or a red 3. Past the 3/5 Watch threshold.
Decline sigma
6.7σ
Drop from local high over the last 20 bars, expressed in units of the stock's typical daily volatility (2.74% per day). Past the ≥6σ Amber threshold.

The structural read

What price action says about COLL.

COLL qualifies for the Amber List on decline depth — down -34.3% from its rolling 252-day high.

Cross-confirmation: also showing 3/5 bearish time frames.

Cross-confirmation: decline sigma also reads 6.7σ over 20 bars.

Upstream TFC read: bearish alignment, current phase daily. Last bar types — daily 2D (red), weekly 3 (red), monthly 2U (red).

Earnings on file: 2026-02-26. Tiering is unaffected by earnings dates — listings reflect price structure only.

52-week range

52W low $23.23 36.8% of range 52W high $50.79

Sector context · Healthcare

194 other Healthcare tickers are on Broken Stocks.

89 Red List
46 Amber
59 Watch
-36.0% Median decline

Worst in sector: OPRX (-77.1%). Least-bad: MRNA (-20.1%). See all Healthcare listings →

Questions about COLL

What people ask.

Why is COLL on Broken Stocks?

COLL qualifies for the Amber List on decline depth. It is down -34.3% from its rolling 252-day high of $50.79, set on 2025-12-29 — 150d ago.

Is COLL a falling knife?

Not by the strict technical definition. COLL is down -34.3% from its 52-week high, but that high was set 150d ago — more than 120 days. A falling knife is usually a recent breakdown from a fresh high, not an established multi-quarter downtrend. COLL is still on the Amber List for decline depth, but the freshness component of a falling knife is missing.

Is COLL a buy?

Broken Stocks does not issue buy or sell recommendations. The list is a rules-based technical warning system. It tracks structural decline depth and recency — not company quality, management, fundamentals, or news. Always do your own research and consult a licensed advisor.

Where is COLL trading inside its 52-week range?

At $33.37, COLL sits 36.8% of the way from its 52-week low ($23.23) to its 52-week high ($50.79). A reading below 25% indicates price is hugging the bottom of the range; above 75%, the top.

How fast has COLL been declining?

The current 34.3% decline accrued over 150d, which annualizes to roughly -83.5% per year. Annualized pace is a sanity check — a 30% decline in three months is a different signal than a 30% decline over two years.

How does COLL compare to its sector?

There are 194 other Healthcare tickers on Broken Stocks: 89 Red, 46 Amber, 59 Watch, with 108 showing recovering structural signals. Median sector decline is -36.0% — COLL's decline is shallower than the sector median.

Does COLL's earnings date affect its tier?

No. Tiering is decided purely by decline depth and recency of the rolling-high date. The earnings date on file (2026-02-26) is shown for reference only — listings can move tier between scans based on closing prices, regardless of fundamentals or news events.